Effects of short-term trimethoprim-sulfamethoxazole administration on thyroid function in dogs

Journal of the American Veterinary Medical Association

Volumn 221, Issue 6, 2002, Pages 802-806

  Williamson, Nicola L ^a   Frank, Linda A ^a   Hnilica, Keith A ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; THYROTROPIN; THYROXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG ANTAGONISM; LEUKOCYTE COUNT; NEUTROPENIA; NONHUMAN; REFERENCE VALUE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ANIMALIA; CANIS FAMILIARIS;

EID: 0037105710     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2002.221.802     Document Type: Article

References (33)

1. White SD. Review article: systemic treatment of bacterial skin infections of dogs and cats. Vet Dermatol 1996;7:133-143.
2. Ihrke PJ. Antibacterial therapy in dermatology. In: Bonagura JD, ed. Kirk's current veterinary therapy XII. Philadelphia: WB Saunders Co, 1986;566-571.
3. Messinger LM, Beale KM. A blinded comparison of the efficacy of daily and twice daily trimethoprim-sulfadiazine and daily sulfadimethoxine-ormetoprim therapy in the treatment of canine pyoderma. Vet Dermatol 1993;1:13-18.
4. Scott WS, Miller WH Jr, Griffin CE. Bacterial skin diseases. In: Scott WS, Miller WH Jr, Griffin CE, eds. Muller and Kirk's small animal dermatology. 6th ed. Philadelphia: WB Saunders Co, 2001;274-335.
5. Tribrissen [package insert]. Union, NJ: Schering-Plough Animal Health Corp, 2001.
6. Torres SMF, McKeever PJ, Jonston SD. Hypothyroidism in a dog associated with trimethoprim-sulphadiazine therapy. Vet Dermatol 1996;7:105-108.
7. Gookin JL, Trepanier LA, Bunch SE. Clinical hypothyroidism associated with trimethoprim-sulfadiazine administration in a dog. J Am Vet Med Assoc 1999;214:1028-1031.
8. Plumb D. Veterinary drug handbook. 3rd ed. Ames, Iowa: Iowa State University Press, 1999;680-684.
9. Lording PM, Bellamy JEC. Trimethoprim and sulfadiazine: adverse effects of long term administration in dogs. J Am Anim Hosp Assoc 1978;14:410-417.
10. Giger U, Werner LL, Millichamp NJ, et al. Sulfadiazine-induced allergy in six Doberman Pinschers. J Am Vet Med Assoc 1985; 186:479-484.
11. Cohen HN, Beastall GH, Ratcliffe WA, et al. Effects on human thyroid function of sulphonamide and trimethoprim combination drugs. Br Med J 1980;281:646-647.
12. DeGroot LJ, Larsen PR, Hennemann G. Effects of drugs, disease, and other agents on thyroid function; the nomhyroidal illness syndrome. In: DeGroot LJ, Larsen PR, Hennemann G, eds. The thyroid and its diseases. 6th ed. New York: Churchill Livingstone, 1996;137-187.
13. Takayama S, Aihara K, Onodera T, et al. Antithyroid effects of propylthiouracil and sulfamonomethoxine in rats and monkeys. Toxicol Appl Pharmacol 1986;82:191-199.
14. Swarm RL, Roberts GKS, Levy AC, et al. Observations on the thyroid gland in rats following administration of sulfamethoxazole and trimethoprim. Toxicol Appl Pharmacol 1973;24:351-363.
15. Kobayashi R, Harada A, Kanno Y, et al. Potentiation of goitrogenic action of sulfonamide by trimethoprim (37114). Proc Soc Exp Biol Med 1973;142:776-780.
16. Panciera DL, Post K. Effect of oral administration of sulfadiazine and trimethoprim in combination on thyroid function in dogs. Can J Vet Res 1992;56:349-352.
17. Hall IA, Campbell KL, Chambers MD, et al. Effect of trimethoprim/sulfamethoxazole on thyroid function in dogs with pyoderma. J Am Vet Med Assoc 1993;202:1959-1962.
18. DeGroot LJ, Larsen PR, Hennemann G. Normal physiology of the hypothalamic-pituitary-thyroidal system and its relation to the neural system and other endocrine glands. In: DeGroot LJ, Larsen PR, Hennemann G, eds. The thyroid and its diseases. 6th ed. New York: Churchill Livingstone, 1996;113-136.
19. Larsen PR, Silva JE, Kaplan MM, Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocrinol Rev 1981;2:87-102.
20. Larsen PR. Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 1982;306:23-32.
21. Williams DA, Scott-Moncrieff C, Bruner J, et al. Validation of an immunoassay for canine thyroid-stimulating hormone and changes in serum concentration following induction of hypothyroidism in dogs. J Am Vet Med Assoc 1996;209:1730-1732.
22. Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am 2001;30:245-264, vii.
23. Feldman EC, Nelson RW. Hypothyroidism. In: Canine and feline endocrinology and reproduction. Philadelphia: WB Saunders Co, 1996;68-117.
24. Nachreiner RF, Refsal KR, Ravis WR, et al. Pharmacokinetics of L-thyroxine after its oral administration in dogs. Am J Vet Res 1993;54:2091-2098.
25. Hitchings GH. Mechanism of action of trimethoprim-sulfamethoxazole-1. J Infect Dis 1973;128(suppl):S433-S436.
26. Herbert V. Metabolism of folic acid in man. J Infect Dis 1973;128(suppl):S601-S606.
27. Weiss DJ. Leukocyte disorders and their treatment. In: Bonagura JD, ed. Kirk's current veterinary therapy XII. Philadelphia: WB Saunders Co, 1995;452-456.
28. Cribb AE, Spielberg SP. An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogs. Vet Res Commun 1990;14:241-252.
29. Cribb AE. Idiosyncratic reactions to sulfonamides in dogs. J Am Vet Med Assoc 1989;195:1612-1614.
30. Trepanier LA. Delayed hypersensitivity reactions to sulfonamides: syndromes, pathogenesis and management. Vet Dermatol 1999;10:241-248.
31. Berger SL, Scagliotti RH, Lund EM. A quantitative study of the effects of Tribrissen on canine tear production. J Am Anim Hosp Assoc 1995;31:236-241.
32. Morgan RV, Bachrach A Jr. Keratoconjunctivitis sicca associated with sulfonamide therapy in dogs. J Am Vet Med Assoc 1982; 180:432-434.
33. Sansom J, Barnett KC, Long RD. Keratoconjunctivitis sicca in the dog associated with the administration of salicylazosulphapyridine (sulphasalazine). Vet Rec 1985;116:391-393.